Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

nifene

Known as: 2-fluoro-3-(2-(3-pyrrolinyl)methoxy)pyridine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Nicotinic acetylcholinergic receptors (nAChR's) have been implicated in several brain disorders, including addiction, Parkinson's… Expand
Review
2014
Review
2014
There have been a number of attempts to study PET radioligands for imaging nicotinic acetylcholine receptors (nAChRs) in the… Expand
2013
2013
[18F]Nifene is an agonist PET radioligand developed to image α4β2∗ nicotinic acetylcholine receptors (nAChRs). This work aims to… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
2013
2013
(-)-[(18) F]Flubatine was selected for clinical imaging of α4 β2 nicotinic acetylcholine receptors because of its high affinity… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2012
2012
The PET radioligand 2-fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (18F-nifene) is an α4β2* nicotinic acetylcholine receptor… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2012
2012
Nicotinic acetylcholine receptors (nAChRs) in the brain are important for cognitive function; however, their specific role in… Expand
2012
2012
Nicotinic acetylcholine receptors (nAChRs) are downregulated in disease conditions such as Alzheimer's and substance abuse… Expand
2011
2011
MicroPET imaging studies using 18F-nifene, a new positron emission tomography (PET) radiotracer for nicotinic acetylcholinergic… Expand
2007
2007
Acetylcholinesterase inhibitors (AChEI's) are used to treat Alzheimer's disease (AD), and the putative mode of action is to… Expand
2006
2006
The alpha4beta2 nicotinic acetylcholine receptor (nAChR) has been implicated in various neurodegenerative diseases. Optimal… Expand